Litigation

Recent Posts

5th Circuit: Mensing Doesn't Make Brand-Name Defendants Liable For Injuries
Posted on 26 Oct 2012 by Tom Moylan

NEW ORLEANS - (Mealey's) The U.S. Supreme Court's ruling that preempts failure-to-warn claims involving generic drugs does not change Louisiana state law and make manufacturers of brand-name versions liable, a Fifth Circuit U.S. Court of Appeals... Read More

Failure To Update Generic Metoclopramide Label Not Preempted, 6th Circuit Says
Posted on 14 Mar 2013 by Tom Moylan

CINCINNATI - (Mealey's) A plaintiff's claim that PLIVA Inc. failed to add a 2004 warning from the Reglan label to its label for generic metoclopramide is not preempted, a panel of the Sixth Circuit U.S. Court of Appeals said March 13 in what it... Read More

Duane Morris Alert: Supreme Court Orders 9th Circuit to Revisit Preemption Ruling Against Generic OTC Ibuprofen Manufacturer
Posted on 21 Nov 2011 by Duane Morris LLP

During its October 28, 2011, conference, the U.S. Supreme Court remanded to the Ninth Circuit its ruling denying federal preemption to a generic manufacturer of ibuprofen to be reassessed in light of the Court's Mensing decision last term. The remand... Read More

Amir Alavi, Todd Mensing Elevated To Name Partners At Houston Commercial Litigation Law Firm AZA
Posted on 27 Sep 2011 by LexisNexis Litigation Resource Community Staff

HOUSTON - Complex commercial litigation attorneys Amir Alavi and Todd Mensing have been elevated to name partners in Houston's Ahmad, Zavitsanos, Anaipakos, Alavi & Mensing P.C. , a dynamic and growing boutique law firm also known as AZA. All... Read More

Supreme Court: Can Generic Drug Maker Be Sued Over Labels?
Posted on 31 Mar 2011 by LexisNexis Litigation Resource Community Staff

WASHINGTON, D.C. - (AP) The Supreme Court seemed split on Wednesday on whether to allow generic drug makers to be sued in state court for not trying to get federal regulators to add warnings about potentially dangerous side effects to their drug labels... Read More